NMD Pharma (private company)

See something wrong or missing? Let us know
Offices:Aarhus
Business model:B2B

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. The company is developing novel treatments to strengthen neuromuscular transmission and muscle function in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have a profound unmet medical need, aiming to improve the quality of life and survival of patients with neuromuscular disorders.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 50M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to NMD Pharma

Name Criteria
Denmark AFYX Therapeutics
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures, Novo Seeds
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures
  • Total raised in a similar range: 10M+ USD
Denmark Draupnir Bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: INKEF Capital, Novo Seeds
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
63%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: INKEF Capital
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures
  • Total raised in a similar range: 10M+ USD
Denmark Antag Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Hoba Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Top